Skip to content
Soania Mathur, a former family physician, who has had Parkinson’s disease for over 25 years, believes she knows what’s best for her. “As patients […]
FNIH’s new Parkinson’s program proves collaboration is key Read More »
While a new report shows childhood vaccination saved over a million lives and averted half a billion cases of disease during the past 30
Childhood vaccination saved more than 1 million lives CDC finds Read More »
The Food and Drug Administration (FDA) on Aug. 6 approved VORANIGO, the first targeted therapy for Grade 2 Isocitrate dehydrogenase (IDH) mutant glioma, a
FDA approves Servier’s VORANIGO for certain brain tumors Read More »
Amidst Typhoon Gaemi, the Biotechnology Innovation Organization (BIO) traveled to Taipei to co-host BIO Asia-Taiwan from July 26-30. Luckily, the weather was no match
BIO travels to Taipei to co-host BIO Asia-Taiwan Read More »
The Inflation Reduction Act (IRA) has already begun to shift the way that innovative companies are investing in future breakthroughs. Over the past few
Measles is raging in the U.S. and other parts of the world—even though it is completely preventable by vaccines. The Centers for Disease Control
Measles triples in U.S. and spikes elsewhere as vaccination lags Read More »
Farm workers considered to be at highest risk of infection with avian flu would receive seasonal influenza vaccinations for fall flu season under a new program
CDC plans seasonal flu vaccine campaign among farm workers at risk of H5N1 Read More »
Believe it or not, flu season is just around the corner. But with vaccination rates still in decline and the ever-mutating cohort of seasonal
Why getting your flu shot is the right move this fall Read More »
Members of the public shared emotional stories about how practices by pharmacy benefit managers (PBMs) increase the cost of drugs, reduce patient access, and
Emotional testimonies expose harmful impact of PBMs at FTC hearing Read More »
The Federal Trade Commission will host an open meeting this morning, and fortunately, drug middlemen are on the agenda. The meeting will review the findings
FTC to air grievances with PBMs’ abusive practices Read More »
